Testing DMT to Treat Depression Psychoactive drug DMT (aka N, N-Dimethyltryptamine) is known for its life-altering, metaphysical trips, but scientists are now looking into its potential to treat depression. Small Pharma, a Canadian drug development company, is working on combining DMT with regular therapy to ease depression in treatment-resistant patients. In September, the company completed phase one of clinical trials—the first company to do so—by …
When cannabis-based wellness brand Papa & Barkley launched in 2016, the world was a very different place. While Adam Grossman (co-founder and executive chairman) and Guy Rocourt (co-founder, president and chief product officer) and their team continue to focus on cannabis products that positively affect the mind and body, they’re also acutely aware of the different stresses of the “new” existence we’re collectively experiencing. It makes …
New Exhibition Shines Light on Influential Swiss Artist Sophie Taeuber-Arp A significant figure in various movements including Constructivism, Dada and Modernism, Sophie Taeuber-Arp historically has been “left outside the fine art canon,” but a new exhibition—beginning at London’s Tate and traveling to Basel and New York—is set to shine a light on her immense career. Making art from 1906 to 1943, Taeuber-Arp worked with and …
